Literature DB >> 29788872

Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy.

Qi Zhang1, Sudan Wang1, Ruirui Qiao2, Michael R Whittaker2, John F Quinn2, Thomas P Davis2,3, Hongjun Li1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  MRI; Magnetic nanoparticle; cancer; diagnosis; hepatocellular carcinoma; molecular imaging.

Mesh:

Substances:

Year:  2018        PMID: 29788872     DOI: 10.2174/1381612824666180516111939

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

Review 1.  Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment.

Authors:  Dongxu Zhao; Jian Cao; Lei Zhang; Shaohua Zhang; Song Wu
Journal:  Biosensors (Basel)       Date:  2022-05-17

2.  Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.

Authors:  Wanjun Gao; Xiaohua Chen; Wei Chi; Ming Xue
Journal:  Int J Mol Med       Date:  2020-09-09       Impact factor: 4.101

3.  Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma.

Authors:  Lili Chen; Wenzhong Hong; Siliang Duan; Yiping Li; Jian Wang; Jianmeng Zhu
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.